Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:11:55 EDT Sun 12 Apr 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  3.63.91·3.950.53.94+0.071.8128.04773253.84  3.97  3.843.97  2.0216:00:00Feb 1115 min RT 2¢
TSX - T3.63.91·3.950.53.94+0.071.895.03591743.84  3.97  3.843.97  2.0216:00:0015 min
NEO ATS - U 3.93+0.061.61.86163.88  3.97  3.8815:57:0515 min
Alpha - A 3.92+0.051.33.211143.88  3.92  3.8415:42:2215 min
CSE ATS - P 3.88+0.010.36.625203.89  3.92  3.8614:40:5215 min
CXC - X 3.93+0.061.60.2123.91  3.93  3.9115:24:0915 min
CX2 - H 3.84-0.03-0.80.2113.84  3.84  3.8410:47:5515 min
CXD - D 3.92+0.051.31.75253.88  3.955  3.85515:56:0015 min
MatchNOW - M 3.876.12135    Sep 11/2015 min
Lynx - Y 3.92+0.051.313.249373.93  3.95  3.8815:48:5915 min
CS2 - S 3.870.0501    Oct 1015 min

Recent Trades - Last 10 of 325
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T3.940.0710014 Virtu ITG1 AnonymousKQ
16:00:00T3.940.0710014 Virtu ITG1 AnonymousKQ
15:59:59T3.920.052001 Anonymous79 CIBCK
15:59:59T3.920.052001 Anonymous14 Virtu ITGK
15:59:59M3.930.0610079 CIBC14 Virtu ITG
15:59:56U3.940.0771 Anonymous79 CIBCE
15:59:56T3.940.06757 Interactive14 Virtu ITG
15:57:51M3.910.047779 CIBC79 CIBCE
15:57:50D3.960.09880 National Bank80 National BankE
15:57:05U3.930.061001 Anonymous79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-02-11 17:42C:MDP2.81SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-02-11 17:42C:MDP2.81SEDAR Interim MD & ASEDAR Interim MD & A
2026-02-11 17:31C:MDP2.81News ReleaseMedexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
2026-02-03 17:31C:MDP2.89News ReleaseMedexus Schedules Third Fiscal Quarter 2026 Conference Call
2025-11-20 16:39C:MDP2.61News ReleaseMedexus arranges NCIB to buy back up to 10% of float
2025-11-17 18:35C:MDP2.70News ReleaseMedexus obtains $51-million (U.S.) credit, plans NCIB
2025-11-12 18:18C:MDP2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 18:18C:MDP2.70SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-12 18:07C:MDP2.70News ReleaseMedexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
2025-11-05 00:49C:MDP2.69News ReleaseMedexus Pharmaceuticals to release Q2 results Nov. 12
2025-09-26 04:40C:MDP2.97News ReleaseMedexus shareholders approve all proposals at AGM
2025-08-12 17:44C:MDP2.75SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-12 17:38C:MDP2.75SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-12 17:30C:MDP2.75News ReleaseMedexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection
2025-08-05 17:31C:MDP2.89News ReleaseMedexus Schedules First Fiscal Quarter 2026 Conference Call
2025-08-05 17:30C:MDP2.89News ReleaseMedexus's Grafapex add-on payment okayed by Medicare
2025-06-25 18:40C:MDP3.35SEDAR MD & ASEDAR MD & A
2025-06-25 18:40C:MDP3.35SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 18:29C:MDP3.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 18:16C:MDP3.35News ReleaseMedexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States